Compositions comprising TNF-specific antibodies for oral delivery
US8647626B2 · kind B2 · utility
1Cited by
0References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 7, 2013 |
| Grant date | Feb 11, 2014 |
| Priority date | — |
| Expiry date | Jun 7, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In accordance with the invention, the development and use of antibodies within the digestive tract is provided. Antibodies are described that are used to treat disorders associated with altered permeability of the digestive tract. Antibodies are described with increased stability within the environment of the digestive tract. Antibodies are described with enhanced permeability to a compromised digestive tract.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.